MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字SJ20181019

November 4, 2021

S20181019

Drug Information

阿达木单抗注射液

修美乐

注射剂

40mg/0.4ml预填充式注射笔

生物制品

November 4, 2021

November 3, 2026

Company Information

Applicant Company

Knollstrasse, 67061 Ludwigshafen,Germany

Manufacturing Company

vetter pharma-fertigung gmbh & co.kg

Schützenstrasse 87 and 99-101, 88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath